Regulation of cell death by cell cycling
Regulation of cell death by cell cycling
批准号:
13043013
负责人:
TSUBATA Takeshi
金额:
$67.97万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cellular defects that perturb cell cycle progression induce checkpoint-mediated cell cycle arrest, and the defect in this arrest causes cell death. However, checkpoint-independent cell cycle arrest is known to either induce or block cell death. In this study, we addressed mechanisms for cell cycling-mediated regulation of cell death and its biological significance. By using B lymphoma line that undergoes efficient apoptosis upon cell cycle arrest, we established the experimental system in which gene fragments regulating cell cycle arrest-induced apoptosis are enriched We isolated the c-myc gene as a regulator of cell cycle arrestinduced cell death. We further demonstrated that cell cycle arrest induces apoptosis in cells expressing a high level of c-myc, but induces survival in c-myclo cells. This result suggests that cMyc determines whether cell cycling regulates cell death positively or negatively. Further, we isolated genes involved in RNA metabolism such as SMN as regulators of cell cycling-regulated cell death. B lymphocytes undergo cell death upon antigen stimulation, and the antigen-induced cell death is abrogated by CD40 signaling for generating immune responses. We demonstrated that CD40mediated cell survival requires cell cycling, suggesting that regulation of cell death by cell cycling play a crucial role in the immune system. Further, we demonstrated that ROS is generated upon induction of cell death by cell cycle arrest or antigen stimulation, and plays a crucial role in the cell death.
期刊论文(106)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Extopie CD40 ligand expression on B cells trigger intestinal inflammation.
B 细胞上的 Extopie CD40 配体表达引发肠道炎症。
DOI:
--
发表时间:
2004
期刊:
J. Immunol. 172
影响因子:
--
作者:
[Kawamura, T., Kanai, T., Dohi, T., Urushihara, K., Totsuka, T., Iiyama, R., Taneda, C., Yamazaki, M., Nakamura, T., Higuchi, T., Aiba, Y., Tsubata, T., Watanabe, M.]
通讯作者:
M.
Involvement of cell cycle progression in survaival signaling through CD40 in B lymphecyte line WEIII-231.
B 淋巴细胞系 WEIII-231 中细胞周期进程通过 CD40 参与生存信号传导。
DOI:
--
发表时间:
2003
期刊:
Cell. Death. Differ 11
影响因子:
--
作者:
[Hirai, H, Adachi, T., Tsubata, T.]
通讯作者:
T.
T cell-specific loss of Pten leads to defects in central and perilheral tolerance.
T 细胞特异性 Pten 缺失会导致中枢和外周耐受缺陷。
DOI:
--
发表时间:
2001
期刊:
Immunity 14
影响因子:
--
作者:
[Suzuki, A, Tsukio-Yamaguchi M., Ohteki, T, Sasaki, T., Kaisho, T., Kimura, Y., Yoshida, R., Wakeham, A., Higuchi, T., Fukumoto, M., Tsubata, T., Ohashi, P., Koyasu, S., Penninger, J.M., Nkano, T., Mak, T.W.]
通讯作者:
T.W.
Tanaka M., Y.Hirabayashi, T.Sekiguchi, T.Inoue, M.Katsuki, A.Miyajima: "Targeted disruption of Oncostatin M receptor results in altered hematopoiesis."Blood. 102. 3154-3162 (2003)
Tanaka M.、Y.Hirabayashi、T.Sekiguchi、T.Inoue、M.Katsuki、A.Miyajima:“制瘤素 M 受体的靶向破坏会导致造血功能改变。”血液。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Involvement of cell cycle progression in survival signaling through CD40 in B lymphocyte line WEHI-231
B 淋巴细胞系 WEHI-231 中通过 CD40 参与细胞周期进程的生存信号传导
DOI:
--
发表时间:
2004
期刊:
Cell Death Differ. 11
影响因子:
--
作者:
[Hirai, H., Adachi, T., Tsubata, T.]
通讯作者:
T.
共 47 条
Studies on Siglecs expressed on B lymphocytes and their glycan ligands
-
批准号:26293062
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.32万
-
财政年份:2014
-
负责人:TSUBATA Takeshi
-
依托单位:
Carbohydrate recognition of B lymphocyte lectins and their function
-
批准号:23390063
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.32万
-
财政年份:2011
-
负责人:TSUBATA Takeshi
-
依托单位:
Immunogenetic analysis of the resistance to infectious diseases
-
批准号:18406019
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.89万
-
财政年份:2006
-
负责人:TSUBATA Takeshi
-
依托单位:
Roles of membrane-bound lectins in the regulation of immune cells.
-
批准号:15390158
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.66万
-
财政年份:2003
-
负责人:TSUBATA Takeshi
-
依托单位:
Study on transcriptional regulation in CD40 signaling.
-
批准号:12670295
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2000
-
负责人:TSUBATA Takeshi
-
依托单位:
Regulatory mechanisms for self-reactive B cells with somatic mutations in the immunoglobulin genes
-
批准号:09470092
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.45万
-
财政年份:1997
-
负责人:TSUBATA Takeshi
-
依托单位:
Study of CDK inhibitors in B cell immune response
-
批准号:09044292
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$3.65万
-
财政年份:1997
-
负责人:TSUBATA Takeshi
-
依托单位:
Establishment of a spontaneous single gene model for Sjogren's syndrome
-
批准号:07557032
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$1.28万
-
财政年份:1995
-
负责人:TSUBATA Takeshi
-
依托单位:
Control mechanisms for B cell apoptosis and differentiation
-
批准号:06044130
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$9.34万
-
财政年份:1994
-
负责人:TSUBATA Takeshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于c-Myc/GLS1正反馈回路的谷氨酰胺代谢和氨死亡研究加味肺复方干预NSCLC免疫逃逸的作用机制
-
批准号:2026JJ81859
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王华中
-
依托单位:
YBX1介导的HOXA9 mRNA稳定性影响c-MYC转录在胃癌进展中的机制研究
-
批准号:2026JJ82359
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:卢太亮
-
依托单位:
ZDHHC9 介导 c-Myc 的棕榈酰化调控 VSMCs代谢重编程促进胸主动脉夹层进展的作用机制研究
-
批准号:ZCLKLY26H0202
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:孙乐波
-
依托单位:
PUM3通过稳定COL10A1表达调节TGF-β/c-MYC和Notch1通路促进前列腺癌骨转移进程的机制研究
-
批准号:JCZRLH202600428
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
c-Myc 通过上调 SLC1A5 介导的谷氨酰胺代谢重编程增强淋巴瘤细胞铜死亡敏感性
-
批准号:ZCLMRY26H0801
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨陈
-
依托单位:
基于c-Myc/SLC1A5轴研究参芪消癥饮重编程肺癌谷氨酰胺代谢诱导免疫原性细胞死亡的机制
-
批准号:2026JJ82571
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭玲娟
-
依托单位:
CUEDC2通过激活糖酵解介导的c-Myc蛋白乳酸化修饰上调PD-L1促进非小细胞肺癌免疫逃逸的机制研究
-
批准号:2026JJ81641
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:佘科霖
-
依托单位:
靶向ZNF471糖基化通过调控c-Myc/PD-L1轴重塑免疫微环境增强舌鳞癌免疫治疗疗效的机制研究
-
批准号:2026JJ81965
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王鸿涵
-
依托单位:
c-Myc/ASS1介导肠上皮细胞瓜氨酸耗竭在急性放射性小肠损伤中的作用机制研究
-
批准号:2026JJ80904
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杜洁
-
依托单位:
RGS5通过c-Myc/STAT3途径调控PD-L1进而抑制免疫细胞浸润导致胃癌免疫治疗抵抗
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:杨震伟
-
依托单位: